留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

糖化血红蛋白筛查青春期前儿童血糖异常的效果研究

娄珂 董彬 邓睿 周斯亮 李星秀 马军

娄珂, 董彬, 邓睿, 周斯亮, 李星秀, 马军. 糖化血红蛋白筛查青春期前儿童血糖异常的效果研究[J]. 中国学校卫生, 2021, 42(10): 1544-1547. doi: 10.16835/j.cnki.1000-9817.2021.10.024
引用本文: 娄珂, 董彬, 邓睿, 周斯亮, 李星秀, 马军. 糖化血红蛋白筛查青春期前儿童血糖异常的效果研究[J]. 中国学校卫生, 2021, 42(10): 1544-1547. doi: 10.16835/j.cnki.1000-9817.2021.10.024
LOU Ke, DONG Bin, DENG Rui, ZHOU Siliang, LI Xingxiu, MA Jun. Effectiveness effects of screening elevated blood glucose of pre-pubertal children with HbA1c[J]. CHINESE JOURNAL OF SCHOOL HEALTH, 2021, 42(10): 1544-1547. doi: 10.16835/j.cnki.1000-9817.2021.10.024
Citation: LOU Ke, DONG Bin, DENG Rui, ZHOU Siliang, LI Xingxiu, MA Jun. Effectiveness effects of screening elevated blood glucose of pre-pubertal children with HbA1c[J]. CHINESE JOURNAL OF SCHOOL HEALTH, 2021, 42(10): 1544-1547. doi: 10.16835/j.cnki.1000-9817.2021.10.024

糖化血红蛋白筛查青春期前儿童血糖异常的效果研究

doi: 10.16835/j.cnki.1000-9817.2021.10.024
基金项目: 

国家自然科学基金 81903344

北京市优秀人才培养资助项目,引进人才计划与启动项目 BMU2017YJ002

详细信息
    作者简介:

    娄珂(1996-),女,河南新乡人,在读硕士,主要研究方向为儿童青少年心血管健康

    通讯作者:

    董彬,E-mail:bindong@bjmu.edu.cn

  • 中图分类号: R446 R179 R725.8

Effectiveness effects of screening elevated blood glucose of pre-pubertal children with HbA1c

  • 摘要:   目的  探讨糖化血红蛋白(HbA1c)筛查青春期前儿童血糖异常的效果,为儿童血糖异常筛查指标的选择提供科学依据。  方法  2017年整群抽取厦门市未进入Tanner Ⅱ期的1 208名7~10岁学生为研究对象,抽取空腹静脉血检测HbA1c和空腹血糖(FPG)。采用美国糖尿病协会标准将研究对象分为正常组、HbA1c异常组、FPG异常组和联合指标异常组(HbA1c或FPG异常),使用偏相关分析HbA1c与FPG的相关性,使用约登系数法计算FPG为5.6 mmol/L时HbA1c的界值点,使用受试者工作特征曲线(ROC)判断HbA1c的筛查效果。  结果  以HbA1c,FPG及联合指标为筛查指标,儿童血糖异常检出率分别为2.2%, 4.0%和5.8%。HbA1c和FPG的偏相关系数为0.15(P < 0.01),女生组、非超重组偏相关系数较高(r值分别为0.22,0.16)。FPG为5.6 mmol/L时,对应的HbA1c界值点为5.15%。以联合指标为参照标准,FPG和HbA1c的ROC曲线下面积(95%CI)分别为0.84(0.79~0.90)和0.69(0.63~0.74)。  结论  青春期前儿童HbA1c和FPG的相关性较低,HbA1c筛查血糖异常的效果与FPG相比存在差异。建议同时使用HbA1c和FPG筛查青春期前儿童血糖异常。
  • 表  1  不同组别青春期前儿童FPG及HbA1c指标分布比较

    Table  1.   Comparison of FPG and HbA1c of pre-pubertal children in different subgroups

    组别 人数 FPG HbA1c 联合指标异常组
    检出人数 χ2 P 检出人数 χ2 P 检出人数 χ2 P
    性别
      男 609 29(4.8) 2.00 0.16 9(1.5) 2.65 0.10 37(6.1) 0.18 0.67
      女 599 19(3.2) 17(2.8) 33(5.5)
    地区*
      城市 1 138 46(4.0) 0.01 0.94 24(2.1) 0.01 0.93 66(5.8) 0.00 0.99
      乡村 52 2(3.9) 1(2.8) 3(5.8)
    肥胖程度
      非超重 882 35(72.9) 0.00 0.99 19(73.1) 0.00 0.99 51(72.9) 0.00 0.98
      超重/肥胖 326 13(27.1) 7(26.9) 19(27.1)
      注: ()内数字为检出率/%;*表示人数有缺失。
    下载: 导出CSV

    表  2  不同组别FPG为5.6 mmol/L对应的HbA1c界值点

    Table  2.   The cutoffs of HbA1c when FPG was 5.6 mmol/L in different subgroups

    组别 选项 人数 界值/% 约登系数/% 灵敏度 特异度 AUC
    性别 609 5.15 0.16 0.79 0.37 0.58
    599 5.25 0.29 0.68 0.60 0.64
    实足年龄/岁 7 465 5.45 0.25 0.41 0.84 0.63
    8 544 5.15 0.22 0.83 0.39 0.61
    9~10 199 5.15 0.28 0.88 0.41 0.64
    肥胖程度 非超重 882 5.25 0.21 0.63 0.59 0.61
    超重/肥胖 326 5.15 0.12 0.77 0.35 0.56
    合计 1 208 5.15 0.16 0.77 0.39 0.58
    注: AUC为ROC曲线下面积。
    下载: 导出CSV
  • [1] FU J F, LIANG L, GONG C X, et al. Status and trends of diabetes in Chinese children: analysis of data from 14 medical centers[J]. World J Pediatr, 2013, 9(2): 127-134. doi: 10.1007/s12519-013-0414-4
    [2] DABELEA D, MAYER-DAVIS E J, SAYDAH S, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009[J]. JAMA, 2014, 311(17): 1778-1786. doi: 10.1001/jama.2014.3201
    [3] NCD Risk Factor Collaboration(NCD-RisC). Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331, 288 participants[J]. Lancet Diabetes Endocrinol, 2015, 3(8): 624-637. doi: 10.1016/S2213-8587(15)00129-1
    [4] BARRY E, ROBERTS S, OKE J, et al. Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions[J]. BMJ, 2017, 356: i6538. http://www.onacademic.com/detail/journal_1000040320013110_5651.html
    [5] CHEN Y, ZHANG P, WANG J, et al. Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study[J]. Diabetologia, 2021. DOI: 10.1007/s00125-021-05401-x.
    [6] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华糖尿病杂志, 2021, 13(4): 315-409. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ202106003.htm

    Chinese Diabetes Society. Guidelines for the prevention and control of type 2 diabetes in China (2020 Edition)[J]. Chin J Diabet, 2021, 13(4): 315-409. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ202106003.htm
    [7] American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2021[J]. Diabetes Care, 2021, 44(Suppl 1): S15-S33. http://www.ncbi.nlm.nih.gov/pubmed/30559228
    [8] COWIE C C, RUST K F, BYRD-HOLT D D, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006[J]. Diabetes Care, 2010, 33(3): 562-568. doi: 10.2337/dc09-1524
    [9] 李丹, 史慧静, 张越, 等. Tanner分期看图自评法在城市青少年中的适用性研究[J]. 中国学校卫生, 2012, 33(9): 1029-1032. https://www.cnki.com.cn/Article/CJFDTOTAL-XIWS201209002.htm

    LI D, SHI H J, ZHANG Y, et al. Applicability of drawing based on self-assessment of Tanner stages among urban Chinese adolescents[J]. Chin J Sch Health, 2012, 33(9): 1029-1032. https://www.cnki.com.cn/Article/CJFDTOTAL-XIWS201209002.htm
    [10] 国家卫生和计划生育委员会. 学龄儿童青少年超重与肥胖筛查WS/T 586—2018[S]. 北京: 中国标准出版社, 2018.

    National Health and Family Planning Commission of the People's Republic of China. Screening for overweight and obesity among school-age children and adolescents WS/T 586-2018[S]. Beijing: Standards Press of China, 2018.
    [11] ALI M K, BULLARD K M, SAYDAH S, et al. Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014[J]. Lancet Diabetes Endocrinol, 2018, 6(5): 392-403. doi: 10.1016/S2213-8587(18)30027-5
    [12] VINER R, WHITE B, CHRISTIE D. Type 2 diabetes in adolescents: a severe phenotype posing major clinical challenges and public health burden[J]. Lancet, 2017, 389(10085): 2252-2260. doi: 10.1016/S0140-6736(17)31371-5
    [13] KAPADIA C, ZEITLER P, DRUGS, et al. Hemoglobin A1c measurement for the diagnosis of Type 2 diabetes in children[J]. Int J Pediatr Endocrinol, 2012, 2012(1): 31. doi: 10.1186/1687-9856-2012-31
    [14] BUSE J B, KAUFMAN F R, LINDER B, et al. Diabetes screening with hemoglobin A1c versus fasting plasma glucose in a multiethnic middle-school cohort[J]. Diabetes Care, 2013, 36(2): 429-435. doi: 10.2337/dc12-0295
    [15] NOWICKA P, SANTORO N H, LIU H D, et al. Utility of hemoglobin A1c for diagnosing prediabetes and diabetes in obese children and adolescents[J]. Diabetes Care, 2011, 34(6): 1306-1311. doi: 10.2337/dc10-1984
    [16] LEE J M, WU E L, TARINI B, et al. Diagnosis of diabetes using hemoglobin A1c: should recommendations in adults be extrapolated to adolescents?[J]. J Pediatr, 2011, 158(6): 947-952. doi: 10.1016/j.jpeds.2010.11.026
    [17] EHEHALT S, WIEGAND S, KÖRNER A, et al. Low association between fasting and OGTT stimulated glucose levels with HbA1c in overweight children and adolescents[J]. Pediatr Diabetes, 2017, 18(8): 734-741. doi: 10.1111/pedi.12461
    [18] FENG L, NIAN S, ZHAO Y, et al. Higher HbA1c and/or glucose levels alter the association patterns between glycated hemoglobin and fasting glucose levels[J]. Diabetes Res Clin Pract, 2018, 142: 353-362. doi: 10.1016/j.diabres.2018.06.011
    [19] CHAN C L, PYLE L, NEWNES L, et al. Continuous glucose monitoring and its relationship to hemoglobin A1c and oral glucose tolerance testing in obese and prediabetic youth[J]. J Clin Endocrinol Metab, 2015, 100(3): 902-910. doi: 10.1210/jc.2014-3612
    [20] HERMAN W H. Are there clinical implications of racial differences in HbA1c?Yes, to not consider can do great harm![J]. Diabetes Care, 2016, 39(8): 1458-1461. doi: 10.2337/dc15-2686
    [21] HERMAN W H, MA Y, UWAIFO G, et al. Differences in A1c by race and ethnicity among patients with impaired glucose tolerance in the diabetes prevention program[J]. Diabetes Care, 2007, 30(10): 2453-2457. doi: 10.2337/dc06-2003
    [22] SELVIN E, STEFFES M W, BALLANTYNE C M, et al. Racial differences in glycemic markers: a cross-sectional analysis of community-based data[J]. Ann Int Med, 2011, 154(5): 303-309. doi: 10.7326/0003-4819-154-5-201103010-00004
    [23] WANG L, GAO P, ZHANG M, et al. Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013[J]. JAMA, 2017, 317(24): 2515-2523. doi: 10.1001/jama.2017.7596
    [24] TRYGGESTAD J B, WILLI S M. Complications and comorbidities of T2DM in adolescents: findings from the TODAY clinical trial[J]. J Diabetes Complications, 2015, 29(2): 307-312. doi: 10.1016/j.jdiacomp.2014.10.009
    [25] 董艳丽. 糖尿病筛查中应用空腹血糖联合糖化血红蛋白检测的临床价值[J]. 中国妇幼健康研究, 2017, 28(S4): 121. https://www.cnki.com.cn/Article/CJFDTOTAL-SANE2017S4140.htm

    DONG Y L. The performance of FPG combined with HbA1c in diabetes screening[J]. Chin J Woman Child Health Res, 2017, 28(S4): 121. https://www.cnki.com.cn/Article/CJFDTOTAL-SANE2017S4140.htm
  • 加载中
表(2)
计量
  • 文章访问数:  630
  • HTML全文浏览量:  297
  • PDF下载量:  35
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-04-26
  • 修回日期:  2021-08-15
  • 网络出版日期:  2021-10-25
  • 刊出日期:  2021-10-25

目录

    /

    返回文章
    返回